STAT - Reporting from the frontiers of health and medicine

Biotech

First Opinion

By Chase T.M. Anderson

Health

Health Covid-19 vaccine trials from AstraZeneca, Johnson & Johnson to restart
Health Universal mask use could save 130,000 U.S. lives by the end of February, new study estimates
Pharma FDA pushes drug companies to include younger people in breast cancer drug trials
Biotech Why biotech is betting big on SPACs
First Opinion Science journal editors shouldn’t contribute to politicizing science

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Health Canada releases final version of controversial regulations for controlling drug prices
Foghorn Therapeutics raises $120 million in IPO
‘A matter of life and death’: Why a Brazilian lawmaker wants compulsory licensing for Covid-19 products

A STAT Investigation

Special Report

Health

By Gabrielle Glaser

Health

By Amy Sokolow

Heavyweights

Politics

Health FDA shows signs of cold feet over emergency authorization of Covid-19 vaccines
Health The Covid-19 Tracker
Special Report The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond
Health CDC expands definition of ‘close contacts,’ after study suggests Covid-19 can be passed in brief interactions
Health Covid-19 vaccine trials from AstraZeneca, Johnson & Johnson to restart
Health CDC expects ‘community spread’ of coronavirus, as top official warns disruptions could be ‘severe’
Health Amid pandemic, U.S. has seen 300,000 ‘excess deaths,’ with highest rates among people of color
First Opinion Community outbreaks of Covid-19 often emerge after Trump’s campaign rallies